440 related articles for article (PubMed ID: 27496774)
21. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
[TBL] [Abstract][Full Text] [Related]
22. Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine.
Mohamadzadeh M; Durmaz E; Zadeh M; Pakanati KC; Gramarossa M; Cohran V; Klaenhammer TR
Future Microbiol; 2010 Aug; 5(8):1289-96. PubMed ID: 20722604
[TBL] [Abstract][Full Text] [Related]
23. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains.
Franciosa G; Maugliani A; Scalfaro C; Aureli P
PLoS One; 2009; 4(3):e4829. PubMed ID: 19287483
[TBL] [Abstract][Full Text] [Related]
24. Production of recombinant botulism antigens: a review of expression systems.
Moreira GM; Cunha CE; Salvarani FM; Gonçalves LA; Pires PS; Conceição FR; Lobato FC
Anaerobe; 2014 Aug; 28():130-6. PubMed ID: 24930432
[TBL] [Abstract][Full Text] [Related]
25. Identification of the pXO1 plasmid in attenuated Bacillus anthracis vaccine strains.
Liang X; Zhang H; Zhang E; Wei J; Li W; Wang B; Dong S; Zhu J
Virulence; 2016 Jul; 7(5):578-86. PubMed ID: 27029580
[TBL] [Abstract][Full Text] [Related]
26. Clostridium botulinum: a bug with beauty and weapon.
Shukla HD; Sharma SK
Crit Rev Microbiol; 2005; 31(1):11-8. PubMed ID: 15839401
[TBL] [Abstract][Full Text] [Related]
27. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
[TBL] [Abstract][Full Text] [Related]
28. Protection with a recombinant Hc of Clostridium Botulinum neurotoxin serotype A from Escherichia coli as an effective subunit vaccine.
Yu YZ; Sun ZW; Li N; Wang S; Wang RL; Yu WY
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):261-6. PubMed ID: 18932057
[TBL] [Abstract][Full Text] [Related]
29. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.
Barnard JP; Friedlander AM
Infect Immun; 1999 Feb; 67(2):562-7. PubMed ID: 9916059
[TBL] [Abstract][Full Text] [Related]
30. Structure, Function and Evolution of Clostridium botulinum C2 and C3 Toxins: Insight to Poultry and Veterinary Vaccines.
Chellapandi P; Prisilla A
Curr Protein Pept Sci; 2017; 18(5):412-424. PubMed ID: 27915984
[TBL] [Abstract][Full Text] [Related]
31. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
Yu Y; Yu J; Li N; Wang S; Yu W; Sun Z
Vaccine; 2009 Oct; 27(44):6148-53. PubMed ID: 19712769
[TBL] [Abstract][Full Text] [Related]
32. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.
Lee JS; Pushko P; Parker MD; Dertzbaugh MT; Smith LA; Smith JF
Infect Immun; 2001 Sep; 69(9):5709-15. PubMed ID: 11500447
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
Gao YL; Gao S; Kang L; Nie C; Wang JL
Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939
[TBL] [Abstract][Full Text] [Related]
34. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.
Hill KK; Smith TJ
Curr Top Microbiol Immunol; 2013; 364():1-20. PubMed ID: 23239346
[TBL] [Abstract][Full Text] [Related]
35. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate.
Yu YZ; Li N; Zhu HQ; Wang RL; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2009 May; 27(21):2816-22. PubMed ID: 19428892
[TBL] [Abstract][Full Text] [Related]
36. Evolution of Chromosomal Clostridium botulinum Type E Neurotoxin Gene Clusters: Evidence Provided by Their Rare Plasmid-Borne Counterparts.
Carter AT; Austin JW; Weedmark KA; Peck MW
Genome Biol Evol; 2016 Mar; 8(3):540-55. PubMed ID: 26936890
[TBL] [Abstract][Full Text] [Related]
37. An electrochemiluminescence assay for the detection of bio threat agents in selected food matrices and in the screening of Clostridium botulinum outbreak strains associated with type A botulism.
Sachdeva A; Singh AK; Sharma SK
J Sci Food Agric; 2014 Mar; 94(4):707-12. PubMed ID: 23873138
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
Shi DY; Chen BY; Mao YY; Zhou G; Lu JS; Yu YZ; Zhou XW; Sun ZW
Hum Vaccin Immunother; 2019; 15(3):755-760. PubMed ID: 30433836
[TBL] [Abstract][Full Text] [Related]
39. Botulinum neurotoxin X lacks potency in mice and in human neurons.
Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
[TBL] [Abstract][Full Text] [Related]
40. Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins.
Hill KK; Xie G; Foley BT; Smith TJ
Toxicon; 2015 Dec; 107(Pt A):2-8. PubMed ID: 26368006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
